Ethambutol

  1. Short-course anti-TB therapy followed regression of reactivated focus
    Case report of ICI-induced TB reactivation managed with short-course anti-TB therapy followed by continued checkpoint inhibitor monotherapy, suggesting personalized management alternatives to.
  2. Isoniazid monoresistance and alopecia occurred together in one TB case
    Severe alopecia developed in a 22-year-old woman with isoniazid-monoresistant tuberculosis after starting treatment. Hair regrowth occurred after discontinuing isoniazid, highlighting the.